Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. (2016)

First Author: Armstrong MJ
Attributed to:  Overcoming immunological barriers to regenerative medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(15)00803-x

PubMed Identifier: 26608256

Publication URI: http://europepmc.org/abstract/MED/26608256

Type: Journal Article/Review

Volume: 387

Parent Publication: Lancet (London, England)

Issue: 10019

ISSN: 0140-6736